Detalhe da pesquisa
1.
Response to netakimab in radiographic axial spondyloarthritis patients with different baseline C-reactive protein, sacroiliitis evaluated by MRI and peripheral joint involvement status: a post-hoc analysis of the ASTERA study.
Clin Exp Rheumatol
; 41(3): 718-726, 2023 Mar.
Artigo
Inglês
| MEDLINE | ID: mdl-36062743
2.
Primary efficacy of netakimab, a novel interleukin-17 inhibitor, in the treatment of active ankylosing spondylitis in adults.
Clin Exp Rheumatol
; 38(1): 27-34, 2020.
Artigo
Inglês
| MEDLINE | ID: mdl-31025924
3.
Patients with rheumatoid arthritis facing sick leave or work disability meet varying regulations: a study among rheumatologists and patients from 44 European countries.
Ann Rheum Dis
; 78(11): 1472-1479, 2019 11.
Artigo
Inglês
| MEDLINE | ID: mdl-31427438
4.
The administration of low doses of rituximab followed by hydroxychloroquine, prednisone and low doses of mycophenolate mofetil is an effective therapy in Latin American patients with active systemic lupus erythematosus.
Autoimmun Rev
; 10(2): 108-11, 2010 Dec.
Artigo
Inglês
| MEDLINE | ID: mdl-20804861